云南白药

- 000538

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
云南白药(000538) 利润表
单位:万元
报表日期2023-12-312023-09-302023-06-302023-03-312022-12-31
一、营业总收入3,911,129.222,968,853.212,030,937.291,051,275.103,648,837.26
营业收入3,911,129.222,968,853.212,030,937.291,051,275.103,648,837.26
二、营业总成本3,508,274.992,565,534.641,746,256.68907,960.233,208,716.82
营业成本2,874,451.762,156,176.681,471,323.23763,014.262,688,348.53
营业税金及附加21,080.1515,667.9810,837.284,790.5821,048.94
销售费用499,215.76335,409.25225,768.85120,076.17416,556.39
管理费用105,850.3555,544.7134,444.3816,447.5083,378.43
财务费用-25,924.37-19,124.58-10,599.06-2,776.87-34,287.84
研发费用33,601.3421,860.6014,481.996,408.5933,672.37
资产减值损失----------
公允价值变动收益12,356.6310,364.715,308.8910,315.21-61,990.29
投资收益77,901.0770,322.3542,154.2224,239.9086,819.84
其中:对联营企业和合营企业的投资收益62,853.1564,856.7044,704.8926,721.0773,223.33
汇兑收益----------
三、营业利润483,050.61487,337.72331,334.54173,018.07337,127.92
加:营业外收入1,223.40567.67200.27263.661,358.92
减:营业外支出2,472.841,529.071,206.85566.42786.59
其中:非流动资产处置损失----------
四、利润总额481,801.18486,376.33330,327.97172,715.31337,700.24
减:所得税费用69,545.0774,125.7347,702.0821,142.9653,659.27
五、净利润412,256.11412,250.60282,625.88151,572.35284,040.97
归属于母公司所有者的净利润409,378.21412,347.74282,801.16151,798.84300,112.59
少数股东损益2,877.90-97.14-175.28-226.49-16,071.62
六、每股收益
基本每股收益(元/股)2.29002.31001.58000.85001.9000
稀释每股收益(元/股)2.29002.30001.58000.85001.9000
七、其他综合收益-2,184.78-2,775.64-2,874.94656.16-8,141.24
八、综合收益总额410,071.33409,474.96279,750.94152,228.51275,899.73
归属于母公司所有者的综合收益总额407,233.16409,140.02280,047.43152,277.41293,052.44
归属于少数股东的综合收益总额2,838.17334.94-296.49-48.91-17,152.72
下载全部历史数据到excel中 返回页顶